Protein Kinase Cδ Deficiency Causes Mendelian Systemic Lupus Erythematosus With B Cell‐Defective Apoptosis and Hyperproliferation

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|65|8|2161-2171

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.65, Iss.8, 2013-08, pp. : 2161-2171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B-Cell-Targeted Therapy for Systemic Lupus Erythematosus

By Sabahi Ramin Anolik Jennifer H.

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1933-1948

Adis International

Access to resources Recommend Favorite

B cell depletion in systemic lupus erythematosus

By Leandro Maria J Ehrenstein Michael R

Clinical Medicine, Vol. 7, Iss. 1, 2007-01 ,pp. : 57-59

Royal College Of Physicians

Access to resources Recommend Favorite

Update on systemic lupus erythematosus: autoantibodies and apoptosis

By Gordon Caroline Salmon Mike

Clinical Medicine, Vol. 1, Iss. 1, 2001-01 ,pp. : 10-14

Royal College Of Physicians

Access to resources Recommend Favorite

Targeted B-Cell Depletion Therapy in Childhood-Onset Systemic Lupus Erythematosus: Progress to Date

By Marks Stephen D. Tullus Kjell

Pediatric Drugs, Vol. 9, Iss. 6, 2007-01 ,pp. : 371-378

Adis International

Access to resources Recommend Favorite

Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments

By Liossis Stamatis-Nick C Melissaropoulos Konstantinos

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 833-840

Informa Healthcare

Access to resources Recommend Favorite